For the Inventor, By the Inventor

Enter assignee name

Exton, PA, United States of America

3-Dimensional Pharmaceuticals, Inc.

USPTO Granted Patents = 77

% Expired Patents = 5.2

Forward Citations = 1,551

Loading Chart...

Loading Chart...

93 inventors (with patents filed for the assignee):

Bruce Edward Tomczuk (32 out of 44 patents)

Richard M Soll (32 out of 71 patents)

Tianbao Lu (30 out of 64 patents)

4. Thomas P Markotan (19 out of 30 patents)

5. Francis Raymond Salemme (18 out of 30 patents)

6. Carl R Illig (17 out of 90 patents)

7. Roger Francis Bone (16 out of 24 patents)

8. Michael W Pantoliano (14 out of 24 patents)

9. Nalin L Subasinghe (12 out of 12 patents)

10. Barry A Springer (9 out of 13 patents)

11. Dimitris K Agrafiotis (9 out of 20 patents)

12. Colleen Siedem (8 out of 10 patents)

13. Cynthia L Fedde (7 out of 8 patents)

14. M Jonathan Rudolph (6 out of 12 patents)

15. Alexander W Rhind (6 out of 7 patents)

Core Competencies:

Protease Inhibitors

Integrin Antagonists

Complement Cascade Inhibitors

Aminoguanidines

Thromboresistant Materials

Human Basic Fibroblast Growth Factor

Quinazolinones

Azacycloalkanones

Thiophene Amidines

Heteroaryl Compounds

Chemical Compound Generation

Microplate Thermal Shift Assay

77 patents: Sort by Forward Citations

1. 7482376 - Conjugated complement cascade inhibitors (2009-01-27),

2. 7429603 - C-fms kinase inhibitors (2008-09-30),

3. 7241789 - Substituted indoles and their use as integrin antagonists (2007-07-10),

4. 7138530 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-11-21),

5. 7138374 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 (2006-11-21),

6. 7109354 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-09-19),

7. 7060706 - Quinazolinones (2006-06-13),

8. 6962942 - Azacycloalkanone serine protease inhibitors (2005-11-08),

9. 6900231 - Aminopyridyl-substituted phenyl acetamides as protease inhibitors (2005-05-31),

10. 6890930 - Quinazolinones (2005-05-10),

11. 6872730 - Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists (2005-03-29),

12. 6767722 - Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 (2004-07-27),

13. 6737404 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137 (2004-05-18),

14. 6730783 - Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors (2004-05-04),

15. 6706765 - Aminoguanidines and alkoxyguanidines as protease inhibitors (2004-03-16),

3-Dimensional Pharmaceuticals, Inc. is a leading biopharmaceutical company specializing in the discovery and development of innovative therapeutics. With a focus on 3-dimensional drug design and precision medicine, we strive to create breakthrough treatments for a range of diseases. Our research and development efforts are driven by a dedicated team of scientists and experts in computational chemistry, molecular biology, and drug discovery. Through strategic collaborations and internal capabilities, we aim to bring transformative medicines to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

77 Patents

#4 in Exton, PA

#180 in Pennsylvania

#4,776 in US

#9,741 in the World

Exton, PA, United States of America

3-Dimensional Pharmaceuticals, Inc.

Forward Citations = 1,551

93 inventors:

Bruce Edward Tomczuk (32 out of 44 patents)

Richard M Soll (32 out of 71 patents)

Tianbao Lu (30 out of 64 patents)

4. Thomas P Markotan (19 out of 30 patents)

5. Francis Raymond Salemme (18 out of 30 patents)

Please report any incorrect information to [email protected]

Loading…